Manufacturer
Sentynl Therapeutics
- Products listed
- 4
- Molecules
- 3
- Therapy areas
- 1
Sentynl Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 4 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Sentynl Therapeutics, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Sentynl Therapeutics products through licensed channels, with the documents your regulator needs.
Rare diseases and enzyme replacement
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Nulibry 9.5 mg powder for injectionIntravenous Cold chain | Fosdenopterin | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Zokinvy 50 mg capsuleOral | Lonafarnib | US FDA | Available on request |
| Zokinvy 75 mg capsuleOral | Lonafarnib | US FDA | Available on request |
| Zycubo 2.9 mg powder for injectionSubcutaneous Cold chain | Copper histidinate | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Sentynl Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.